About
Jennifer Smoter is Takeda's Chief Communications & Governance Officer, overseeing global communications, brand leadership, corporate governance, sustainability, and CEO chief of staff responsibilities. She joined Takeda in 2026 after serving as chief communications officer at UnitedHealth Group and chief external affairs officer at Intellia Therapeutics, along with earlier senior communications and brand roles at AbbVie and Abbott Laboratories. She holds a bachelor's degree from Alverno College.
Experience
- TakedaChief Communications & Governance Officercurrent2026 — present
- UnitedHealth GroupSenior Vice President, Chief Communications Officer2021 — 2025Washington, United States
- Intellia Therapeutics, Inc.Chief External Affairs & Communications Officer2015 — 2021
- Amicus Communications & Brand Management, LLCCEO/Owner2015 — 2019
- AbbVieVice President, Public Affairs & Brand2012 — 2015North Chicago, Illinois
- AbbottDivisional Vice President Public Affairs1999 — 2013Greater Chicago Area
- GCI GroupPR Agency1998 — 1999
- DRGM AdvertisingPR Agency1994 — 1997
Education
- Alverno CollegeBA, Communications1990 — 1994
- Waukegan East High School1986 — 1990
- Waukegan High School
Skills & more
Public Relations38Public Affairs27Oncology1Regulatory AffairsClinical DevelopmentProduct Launch10Crisis Communications19Strategic Communications32FDABiotechnology2Drug DevelopmentCorporate Communications14
+7 more
Media RelationsInternal CommunicationsReputation ManagementIntegrated MarketingHealth InsuranceHealthcare IndustryPharmaceutical IndustryLanguages French · Spanish
From Jennifer's professional profile.
Shared employers
Also worked at UnitedHealth Group47
John PrufetaChief Executive Officer and Managing Partner at Medical Excellence CapitalTodd CozzensInvestor at TRANSFORMATION CAPITALRobin BorgInvestor at TRANSFORMATION CAPITALGrant VerstandigFounder, Chairman, & CEO at Red Cell IncubationTroy BurtonHead of Product at Red Cell IncubationJohn NackelFounder and General Partner at Wavemaker Three-Sixty Health
+ 41 more
Also worked at Intellia Therapeutics, Inc.2
Also worked at AbbVie36
Nick GasbarroChief of Staff at QED InvestorsTakehiko SawabeDirector at Beyond Next VenturesAndrew BierDigital Pharma Advisor at Excelerate Health VenturesShwen GweeDigital Pharma Advisor at Excelerate Health VenturesMelissa LokugamageSenior Venture Associate at 82VSScott BrunVenture Partner at Abingworth
+ 30 more
Also worked at Abbott51
Daan BoekhoudtInvestment Analyst at Cottonwood Technology FundJim CaggianoChief Executive Officer, Evolve Biologics at Two Bear CapitalCharles BeyrouthyFounder & Managing Partner at Forma PrimeFederico RaneroVenture Partner at NazcaRamy RiadPresident, Plasma-Derived Therapies Business Unit at Takeda VenturesDani RegaladoStrategy Associate at Commerce Ventures
+ 45 more
Investments
Board seats
Reversal Therapeutics
Per the firm's website.
Colleagues at Takeda Ventures
Akiko Amakawa
CEO Chief of Staff at Takeda Ventures
Andrew S. Plump
Director - President, Research & Development at Takeda Ventures
Asuka Miyabashira
President, Japan Pharma Business Unit at Takeda Ventures
Awny Farajallah
Chief Medical Officer at Takeda Ventures
Christophe Weber
President and CEO, Representative Director at Takeda Ventures
Elaine Shannon
President, Global Supply & Quality at Takeda Ventures
Gabriele Ricci
Chief Data & Technology Officer at Takeda Ventures
Giles Platford
President, International Business Unit at Takeda Ventures